We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CCOLA:BISTCoca-Cola Icecek A.S. Analysis

Data as of 2026-03-16 - not real-time

TRY 70.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CCOLA is trading at 70 TRY, below its 20‑day SMA of 72.28 and 50‑day SMA of 71.09 but above the 200‑day SMA of 56.14, showing longer‑term bullish bias. The 14‑day RSI sits at 46.7, near the neutral zone, while the MACD histogram remains negative (-0.32) and the signal line is flagged “bearish,” hinting at potential short‑term downside pressure. Volatility over the past 30 days is high at 40.7% and beta is only 0.22, meaning price swings are pronounced but largely uncorrelated with the broader market. Support is identified around 64.95 TRY and resistance near 80.40 TRY, giving the stock a ~10% upside to the next technical ceiling. The dividend yield of 2.04% with a modest payout ratio of 21% adds income appeal despite the technical headwinds.
Fundamentally, the company posted a 19% revenue surge, delivering 187.2 bn TRY in sales and a healthy operating margin of 10.1%. Forward earnings are projected at 9.35 TRY per share, translating to a forward P/E of 7.5x, well below the current trailing P/E of 13.9x. The DCF‑derived fair value of 58.9 TRY suggests the market is pricing a premium, yet analyst consensus targets average 91.9 TRY, implying roughly 30% upside. With a strong cash position of 26.3 bn TRY versus debt of 52.1 bn TRY (D/E ≈ 60), the balance sheet can comfortably sustain the dividend and fund modest growth. Given the defensive consumer‑staples positioning, low beta, and attractive yield, the stock appears undervalued and suitable for a buy‑and‑hold strategy.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Negative MACD histogram
  • Price below short‑term SMAs
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 7.5x
  • Revenue growth of 19%
  • Analyst target price indicating 30% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong brand franchise
  • Defensive consumer staples sector
  • Low beta and stable cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth19.10%
Profit Margin7.52%
P/E Ratio13.9
ROE17.05%
ROA8.16%
Debt/Equity60.16
P/B Ratio2.6
Op. Cash FlowTRY27.4B
Free Cash FlowTRY6.4B

Technical Analysis

TrendBullish
RSI46.7
SupportTRY 64.95
ResistanceTRY 80.40
MA 20TRY 72.28
MA 50TRY 71.09
MA 200TRY 56.14
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueTRY 58.93
Target PriceTRY 91.85
Upside/Downside31.22%
GradeUndervalued
TypeGrowth
Dividend Yield2.04%

Risk Assessment

Beta0.22
Volatility40.70%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.